India to Vietnam: Glimepiride Export Trade Route

The India to Vietnam Glimepiride corridor is one of India's established pharmaceutical export routes, with 31 shipments documented worth a combined $1.0M USD. The route is dominated by INVENTIA HEALTHCARE LIMITED, which alone accounts for roughly 88% of all export value, reflecting the consolidated nature of India's glimepiride manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $32.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with glimepiride's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 34.5%, placing it at rank #17 among India's top glimepiride export destinations globally.

On the import side, key buyers of Indian glimepiride in Vietnam include MAXXCARE COMPANY LIMITED, MAXXCARE COMPANY LIMITED., MAXXCARE COMPANY LIMITED. and 6 others. MAXXCARE COMPANY LIMITED is the single largest importer with 13 shipments valued at $476.0K USD.

India's glimepiride exports to Vietnam are driven primarily by a handful of large-scale manufacturers. INVENTIA HEALTHCARE LIMITED with 21 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Vietnam benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INVENTIA HEALTHCARE LIMITED, CADILA PHARMACEUTICALS LIMITED, INVENTIA HEALTHCARE LIMITED — together account for 98% of total trade value on this route. The average shipment value of $32.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as perglim m-2 (each tablet contain: glimepiride usp 2 mg & metformin hcl bp 500 mg) and perglim m-2 (each tablet contain: glimepiride usp 2 mg & metformin hcl bp 500 mg), suggesting that buyers in Vietnam tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MAXXCARE COMPANY LIMITED is the largest importer with 13 shipments worth $476.0K USD — representing 47% of all glimepiride imports from India on this route. A total of 9 buyers are active on this corridor.